🇺🇸 FDA
Patent

US 8664219

Aminopyrimidines useful as inhibitors of protein kinases

granted A61PA61P19/02A61P19/10

Quick answer

US patent 8664219 (Aminopyrimidines useful as inhibitors of protein kinases) held by Vertex Pharmaceuticals Incorporated expires Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Mar 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61P, A61P19/02, A61P19/10, A61P25/00, A61P25/14